260 related articles for article (PubMed ID: 35567662)
1. Interplay of Oral, Mandibular, and Facial Disorders and Migraine.
Teruel A; Romero-Reyes M
Curr Pain Headache Rep; 2022 Jul; 26(7):517-523. PubMed ID: 35567662
[TBL] [Abstract][Full Text] [Related]
2. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
Chen ST; Wu JW
Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
[TBL] [Abstract][Full Text] [Related]
3. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiological role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache].
Meßlinger K
Schmerz; 2020 Apr; 34(2):181-187. PubMed ID: 32103345
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
[TBL] [Abstract][Full Text] [Related]
6. A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial pain.
Romero-Reyes M; Pardi V; Akerman S
Exp Neurol; 2015 Sep; 271():95-103. PubMed ID: 25981890
[TBL] [Abstract][Full Text] [Related]
7. A Pre-Existing Myogenic Temporomandibular Disorder Increases Trigeminal Calcitonin Gene-Related Peptide and Enhances Nitroglycerin-Induced Hypersensitivity in Mice.
Shu H; Liu S; Tang Y; Schmidt BL; Dolan JC; Bellinger LL; Kramer PR; Bender SD; Tao F
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516986
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.
Goadsby PJ
Drugs; 2005; 65(18):2557-67. PubMed ID: 16392873
[TBL] [Abstract][Full Text] [Related]
9. Migraine headache pathophysiology.
Andreou AP; Pereira AD
Handb Clin Neurol; 2023; 198():61-69. PubMed ID: 38043971
[TBL] [Abstract][Full Text] [Related]
10. Characterization of trigeminal C-fiber reactivity through capsaicin-induced release of calcitonin gene-related peptide.
Basedau H; Oppermann T; Gundelwein Silva E; Peng KP; May A
Headache; 2023 Mar; 63(3):353-359. PubMed ID: 36705344
[TBL] [Abstract][Full Text] [Related]
11. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Edvinsson L; Haanes KA; Warfvinge K; Krause DN
Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of migraine--new insights.
Hargreaves RJ; Shepheard SL
Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S12-9. PubMed ID: 10563228
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
Haanes KA; Edvinsson L
CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
[TBL] [Abstract][Full Text] [Related]
14. Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.
Rees TA; Hendrikse ER; Hay DL; Walker CS
Br J Pharmacol; 2022 Feb; 179(3):381-399. PubMed ID: 34187083
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
Durham PL
Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
[TBL] [Abstract][Full Text] [Related]
16. [Neuropeptide effects on the trigeminal system: pathophysiology and clinical significance for migraine].
Messlinger K; Fischer MJ; Lennerz JK
Schmerz; 2011 Aug; 25(4):393-8, 400-1. PubMed ID: 21818718
[TBL] [Abstract][Full Text] [Related]
17. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of calcitonin gene-related peptide in upper spinal cord promotes sensitization of primary trigeminal nociceptive neurons.
Cornelison LE; Hawkins JL; Durham PL
Neuroscience; 2016 Dec; 339():491-501. PubMed ID: 27746346
[TBL] [Abstract][Full Text] [Related]
19. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
[TBL] [Abstract][Full Text] [Related]
20. CGRP mechanism antagonists and migraine management.
Karsan N; Goadsby PJ
Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
